ERFSF (ERFSF) Stock Price & Analysis
ERFSF (ERFSF) fell 0.36% to USD 73.75 as of July 25, 2026 at 08:10 UTC, according to Nexqual real-time market data.
ERFSF last closed at USD 74.02; the session ranged USD 77.5–77.5 on volume of 790 shares. Market capitalization is $12.74B, with a 52-week range of USD 64.95–86.2 (PNK). Source: Nexqual, July 25, 2026 at 08:10 UTC.
Key Statistics (as of July 25, 2026 at 08:10 UTC)
| Price | USD 73.75 |
|---|---|
| Change | ▼ 0.36% (down) |
| Previous Close | USD 74.02 |
| Open | USD 77.5 |
| Day Range | USD 77.5 – 77.5 |
| 52-Week Range | USD 64.95 – 86.2 |
| Volume | 790 shares |
| Market Cap | $12.74B |
| Exchange | PNK |
Technical Analysis (ERFSF)
Nexqual's technical model rates ERFSF "NEUTRAL" based on 3 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 08:10 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 43.28 (neutral) |
| vs SMA50 | Below (USD 74.88) |
| MACD | 0.41 (positive) |
Analyst Ratings (ERFSF)
Wall Street analysts rate ERFSF "None", per Nexqual as of July 25, 2026 at 08:10 UTC.
| Consensus Rating | None |
|---|
Earnings (ERFSF)
| Next Earnings Date | 2026-07-23 |
|---|
Source: Nexqual, July 25, 2026 at 08:10 UTC.
Financials & Fundamentals (ERFSF)
| Total Revenue | $7.39B |
|---|---|
| Revenue Growth (YoY) | +2.50% |
| Gross Margin | +23.13% |
| Operating Margin | +16.17% |
| Profit Margin | +7.17% |
| ROE | +11.33% |
| Debt / Equity | 96.12 |
| Current Ratio | 1.13 |
| Total Cash | $617.80M |
| Total Debt | $4.47B |
| Free Cash Flow | $335.56M |
Source: Nexqual, July 25, 2026 at 08:10 UTC.
Financial Health Score (ERFSF)
Nexqual rates ERFSF's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 08:10 UTC.
| Growth | Mixed — Revenue +5.0% YoY (annual), slow |
|---|---|
| Profitability | Mixed — Gross margin 23%, operating 16% |
| Balance Sheet | Mixed — $618M cash vs $4.47B debt |
| Cash Flow | Mixed — FCF $336M, slim 4.6% margin |
| Efficiency | Mixed — ROE 11%, ROA 6.0% |
Ownership (ERFSF)
| Insider Ownership | +36.50% |
|---|---|
| Institutional Ownership | +34.00% |
| Shares Outstanding | 172.78M |
| Float | 110.49M |
Source: Nexqual, July 25, 2026 at 08:10 UTC.
Leadership (ERFSF)
ERFSF is led by Gilles G. Martin (age 62), Chairman of the Board & CEO, per Nexqual as of July 25, 2026 at 08:10 UTC.
| Chairman of the Board & CEO | Gilles G. Martin (age 62) |
|---|---|
| Executive Director | Valerie Hanote (age 59) |
| Group Administration & CFO | Laurent Lebras |
| Senior Vice President of Food & Feed Testing Europe | Joachim Reichelt |
| Senior Vice President of Environment Testing Europe | Yvoine Remy |
Major Backers & Investors (ERFSF)
Notable institutional backers of ERFSF include Gardner Russo & Quinn, LLC, SEQUOIA FUND INC, FPA FUNDS TRUST-FPA Crescent Fund, according to Nexqual as of July 25, 2026 at 08:10 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Gardner Russo & Quinn, LLC | 1.76% |
| SEQUOIA FUND INC | 1.66% |
| FPA FUNDS TRUST-FPA Crescent Fund | 0.94% |
| T. Rowe Price | 0.39% |
| TRANSAMERICA FUNDS-Transamerica International Equity | 0.29% |
| AMERICAN FUNDS INSURANCE SERIES-International Fund | 0.25% |
| Fidelity | 0.25% |
| Bridge Builder Trust-Bridge Builder International Equity Fund | 0.24% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.57% |
| BlackRock | 0.49% |
Source: Nexqual, July 25, 2026 at 08:10 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BMXMF | Biomerieux 69 Marcy L'Etoile | USD 78.99 | ▼ 1.64% |
| LZAGF | Lonza Group AG | USD 675.41 | ▲ 2.42% |
| SAUHF | STRAUMANN HOLDING AG | USD 118.3 | ▼ 2.99% |
| GNMSF | Genmab A/S | USD 274.5 | ▲ 0% |
| SKHCF | Sonic Healthcare Ltd. | USD 13.8 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 08:10 UTC. This page is informational and not investment advice.